{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:27:01Z","timestamp":1792661221003,"version":"4.5.0"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T00:00:00Z","timestamp":1205366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J of Urology"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p><jats:bold>Objectives:\u2003<\/jats:bold> Botulinum toxin type A (BoNT\/A) proved very effective in therapy for hyperactive detrusor or sphincter dysfunction of neurogenic and non\u2010neurogenic origin. However, therapy may fail. In a search for possible reasons, we investigated the presence of BoNT\/A antibodies (BoNT\/A\u2010AB) in patients who were treated more than once and correlated the presence of antibodies with clinical findings.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> In 25 patients (aged 11\u201375\u2003years; average, 48.3\u2003years) who had experienced at least one previous BoNT\/A detrusor and\/or sphincter injection, BoNT\/A\u2010AB was detected with the mouse diaphragm assay before and within 3\u2003months after the current injection. Clinically, subjective and objective outcomes of this injection session were determined on an efficacy scale.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> In eight patients, BoNT\/A\u2010AB was detected; titers were clearly positive in four patients and were borderline in four patients. The subjective and objective outcomes indicated complete therapy failure in three of four patients who were positive for BoNT\/A\u2010AB. In two patients, BoNT\/A\u2010AB developed after just one injection session.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> Botulinum toxin type A antibodies can develop after injection of BoNT\/A for urologic disorders and the antibodies can lead to therapy failure. In patients with clinically complete therapy failure in whom no obvious other causes can be determined (such as a progressive disease in a patient with multiple sclerosis), screening for BoNT\/A\u2010AB should be carried out.<\/jats:p>","DOI":"10.1111\/j.1442-2042.2008.02016.x","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T01:54:20Z","timestamp":1205459660000},"page":"407-415","source":"Crossref","is-referenced-by-count":61,"title":["Botulinum neurotoxin type A in urology: Antibodies as a cause of therapy failure"],"prefix":"10.1111","volume":"15","author":[{"given":"Heinrich","family":"Schulte\u2010Baukloh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Bigalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut H","family":"Knispel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,29]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)42717-0"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000162035.73977.1c"},{"issue":"4","key":"e_1_2_5_4_2","first-page":"351","article-title":"Successful use of bladder botulinum toxin injection to treat refractory overactive bladder","volume":"169","author":"Chancellor M","year":"2003","journal-title":"J. Urol."},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.06.021"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20022"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.01.030"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1997.6580"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.07.022"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000108844.10235.f1"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000108407.53880.6a"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.11.009"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055087.96356.BB"},{"key":"e_1_2_5_14_2","first-page":"A511","article-title":"Interim results of an observational study of neutralizing antibody formation with the current preparation of botulinum toxin type a treatment for cervical dystonia","volume":"62","author":"Comella CC","year":"2004","journal-title":"Neurology"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200009)15:5<973::AID-MDS1031>3.0.CO;2-X"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21051"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000092049"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1238"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000047963"}],"container-title":["International Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-2042.2008.02016.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-2042.2008.02016.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:06:58Z","timestamp":1697342818000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-2042.2008.02016.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,29]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1442-2042.2008.02016.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-2042.2008.02016.x","archive":["Portico"],"relation":{},"ISSN":["0919-8172","1442-2042"],"issn-type":[{"value":"0919-8172","type":"print"},{"value":"1442-2042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,29]]}}}